Ledger.Open graph →

SEC Form D · filed April 14, 2020

Phio Pharmaceuticals Corp

Offering

$4.4M

Sold

$4.4M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MARLBOROUGH, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Jonathan P. Freeman · Marlborough, MADirector Robert A. Ferrara · Marlborough, MADirector Gerrit Dispersyn · Marlborough, MAExec Curtis A. Lockshin · Marlborough, MADirector Robert J. Bitterman · Marlborough, MADirector Geert Cauwenbergh · Marlborough, MADirector Caitlin Kontulis · Marlborough, MAExec Gibran Mahmud · Dallas, TXDirector Neil Desai · Dallas, TXExec Philip Braner · Dallas, TXDirector David Scheer · New Haven, CTDirector Mark Murray · Dallas, TXExec Brinda Ganguly · Seattle, WADirector Harlan Krumholz · New Haven, CTDirector H P. Dorman · Marlborough, MADirector John B. Fitzgibbons · New York, NYDirector Anish K. Bahl · New York, NYExec Tasabbur C. Hasan · New York, NYDirector Vishesh Rajaram · Chennai, K7Exec Tremayne A. Williams · Morrow, GADirector Beverly Rubin · El Segundo, CADirector Gianna H. Figaro-Sterling · Charlotte, NCDirector H P. Dorman · Marlborough, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗